ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Cancer
Ovarian Cancer
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck

Breast Cancer trials near Montréal, QC, CAN:

Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)

an ionized gas) on the tumor bed after the removal of the tumor in breast cancer patients. The main questions it aims to answer are ...

Enrolling
Breast Cancer
Device: Convertible Plasma Jet
Centre hospitalier de l'Université de Montréal (CHUM)

Montreal, Quebec, Canada

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Tucatinib
Drug: Durvalumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 71 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Saint-Jérôme, Quebec, Canada and 319 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Montreal, Canada and 144 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Active, not recruiting
Breast Cancer
Drug: Abemaciclib
Drug: ARV-471

Phase 1, Phase 2

Pfizer
Pfizer

Montreal, Quebec, Canada and 37 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Active, not recruiting
Breast Cancer
Drug: ARV-471
Drug: Ribociclib

Phase 1, Phase 2

Pfizer
Pfizer

Montreal, Quebec, Canada and 28 other locations

Locations recently updated

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...

Active, not recruiting
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

DualityBio

Montreal, Quebec, Canada and 257 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Eribulin
Drug: Vinorelbine

Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 166 other locations

+/HER2-) advanced breast cancer....

Enrolling
Advanced HR+/HER2- Breast Cancer
Extensive-stage Small Cell Lung Cancer
Drug: ECI830
Drug: fulvestrant

Phase 1, Phase 2

Novartis
Novartis

Montreal, Quebec, Canada and 32 other locations

versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer subjects previously treated with trastuzumab and taxane....

Active, not recruiting
Breast Cancer
Drug: Trastuzumab deruxtecan (T-DXd)
Drug: Ado-trastuzumab emtansine (T-DM1)

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Montreal, Quebec, Canada and 163 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems